We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Tens of thousands of EpiPens, sold by Mylan NV, were recalled worldwide in March following two reports of the life-saving allergy shot failing to work in emergencies